About pathwayhealthadmin

This author has not yet filled in any details.
So far pathwayhealthadmin has created 48 blog entries.

Pathway Health Corp. Reports Third Quarter 2022 Financial Results

2022-11-24T14:31:26+00:00

Adjusted EBITDA loss improved by 20% from previous quarter to $1.3 million compared to $1.7 million in the previous quarter Entered into a $3.5 million revolving line of credit to support working capital and expansion requirements Expanded services to veterans, RCMP and first responders with the acquisition of the operating assets of IRP Health Ltd. [...]

Pathway Health Corp. Reports Third Quarter 2022 Financial Results2022-11-24T14:31:26+00:00

PATHWAY HEALTH CORP. ANNOUNCES CHANGE OF AUDITOR

2022-11-11T15:03:46+00:00

TORONTO, ON, November 11, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to announce the appointment of MNP LLP as its new auditor effective as of November 10, 2022. MNP LLP (the “Successor Auditor”) replaces Grant Thornton LLP (“Grant Thornton”) (the “Former Auditor”) as Pathway’s auditor. The Board [...]

PATHWAY HEALTH CORP. ANNOUNCES CHANGE OF AUDITOR2022-11-11T15:03:46+00:00

Pathway Health Corp. Announces Collaboration Agreement with Sunshine Drugs Family of Pharmacies.

2022-10-31T13:28:30+00:00

TORONTO, ON, October 31, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has signed a Collaboration Agreement (the “Agreement”) with Sunshine Drugs, [...]

Pathway Health Corp. Announces Collaboration Agreement with Sunshine Drugs Family of Pharmacies.2022-10-31T13:28:30+00:00

Pathway Health Corp. Announces Acquisition of Certain Assets of IRP Health Ltd.

2022-10-27T13:30:30+00:00

TORONTO, ON, October 27, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has entered into an arm’s length asset purchase agreement to [...]

Pathway Health Corp. Announces Acquisition of Certain Assets of IRP Health Ltd.2022-10-27T13:30:30+00:00

Pathway Health Corp. Issues Stock Options

2022-09-29T13:46:17+00:00

TORONTO, ON, September 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the grant of 3,505,593 stock options to directors, officers, employees and consultants on September 28, [...]

Pathway Health Corp. Issues Stock Options2022-09-29T13:46:17+00:00

Pathway Health Corp. Reports Second Quarter 2022 Financial Results

2022-08-29T13:13:42+00:00

Second quarter 2022 revenues came in at $2.8 million and were up approximately 9% sequentially over the first quarter 2022. The Company entered into a $1.0 million bridge loan in the second quarter that rolled into a $3.5 million revolving line of credit subsequent to quarter end. The Company has applied for a non-possession sales [...]

Pathway Health Corp. Reports Second Quarter 2022 Financial Results2022-08-29T13:13:42+00:00

PATHWAY ANNOUNCES APPOINTMENT OF MARK GOLDHAR AS BOARD MEMBER

2022-08-25T02:25:05+00:00

TORONTO, ON, August 24, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) ("Pathway" or the "Company") is pleased to announce the appointment of Mr. Mark Goldhar to the board of directors of the Company. Mr. Goldhar will also join the Audit and the Compensation and Governance Committees. Mr. Goldhar has co-founded 12 companies, 4 of [...]

PATHWAY ANNOUNCES APPOINTMENT OF MARK GOLDHAR AS BOARD MEMBER2022-08-25T02:25:05+00:00

CHP UPDATE TO SHAREHOLDERS

2022-08-12T14:03:12+00:00

Three years ago, the government appointed the Science Advisory Committee to recommend guidelines to assist Health Canada in the development of regulations to permit the sales of CBD based Cannabis Health Products (CHPs) in an over the counter (OTC) setting. After much anticipation, the committee announced their recommendation last Thursday. We highlight some key points [...]

CHP UPDATE TO SHAREHOLDERS2022-08-12T14:03:12+00:00

PATHWAY HEALTH CORP. ANNOUCES CHANGES TO BOARD OF DIRECTORS 

2022-08-03T12:35:52+00:00

TORONTO, ON, August 3, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announced today that Mr. Michael Steele has resigned from the Board of Directors of the Company. “Michael has been a highly valued and [...]

PATHWAY HEALTH CORP. ANNOUCES CHANGES TO BOARD OF DIRECTORS 2022-08-03T12:35:52+00:00

PATHWAY ANNOUNCES CREDIT FACILITY

2022-08-02T12:36:25+00:00

TORONTO, ON, July 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") announces that it has entered into an agreement (the “Credit Agreement”) with the Company’s largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. (the "Lender") to establish a $3.5 million credit facility (the “Facility”) (inclusive of all amounts advanced under [...]

PATHWAY ANNOUNCES CREDIT FACILITY2022-08-02T12:36:25+00:00
Go to Top